Study characteristic | N (%) (n=180) |
Sponsor | |
Commercial | 90 (50.0) |
Non-commercial | 81 (45.0) |
Unknown | 9 (5.0) |
Type of study | |
Parallel group | 164 (91.1) |
Cluster | 11 (6.1) |
Crossover | 5 (2.8) |
Multicountry | 45 (25.0) |
Number of countries in multicountry studies—median (IQR) | 7 (3–11) |
Included modality | |
Haemodialysis | 147 (81.7) |
Both hemodialysis and peritoneal dialysis | 17 (9.4) |
Peritoneal dialysis | 16 (8.9) |
Number of participants – median (IQR) | 208 (148–334) |
Number of sites – median (IQR) | 15 (5–38) |
Planned duration of follow-up (months) – median (IQR) | 7 (3–12) |